CNMD CONMED CORP
2026Q1 · CUSIP 207410101 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
236
Δ holders QoQ
-29
Breadth percentile
Top 95%
Whale holders
133
Δ whales
-5
Inst. holding value
$1.2B
New positions
34
Closed positions
63
Price momentum (1Q)
-14.0%
Put / Call
2/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q4 | Top 17% | -7.6% | -15.4% |
| 2023Q3 | Top 17% | -24.2% | -29.6% |
| 2023Q2 | Top 6% | -3.7% | -23.5% |
| 2022Q1 | Top 14% | -13.7% | -23.1% |
| 2020Q3 | Top 19% | +22.6% | +43.1% |
| 2019Q4 | Top 16% | -30.1% | -16.8% |
| 2019Q1 | Top 12% | +18.6% | +40.9% |
| 2018Q2 | Top 8% | -11.6% | -2.7% |
| 2018Q1 | Top 16% | +13.2% | +0.1% |
Options Sentiment
Put holders
2
QoQ: +2
Call holders
1
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
28.8
EPS (TTM)
$1.51
EPS YoY
-64.5%
Revenue (TTM)
$1.4B
Revenue YoY
+5.2%
Net margin
3.4%
ROE
4.5%
Debt ratio
55.6%
FCF (TTM)
$151M
Dividend (TTM)
$0.60
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2025-12-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.